D
Xeris Biopharma Holdings, Inc. XERS
$4.46 $0.030.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue 222.55M 203.07M 187.36M 181.41M 171.36M
Total Other Revenue -- -- -- -- --
Total Revenue 222.55M 203.07M 187.36M 181.41M 171.36M
Cost of Revenue 39.59M 36.83M 34.92M 29.53M 29.30M
Gross Profit 182.96M 166.24M 152.44M 151.88M 142.06M
SG&A Expenses 163.02M 157.38M 160.91M 153.23M 150.87M
Depreciation & Amortization 10.84M 10.84M 10.84M 10.84M 10.84M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 238.94M 230.62M 232.53M 218.60M 216.33M
Operating Income -16.39M -27.55M -45.17M -37.19M -44.98M
Income Before Tax -47.65M -57.10M -65.62M -59.08M -65.34M
Income Tax Expenses -2.58M -2.27M -2.50M 482.00K -942.00K
Earnings from Continuing Operations -45.08 -54.84 -63.11 -59.56 -64.40
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -45.08M -54.84M -63.11M -59.56M -64.40M
EBIT -16.39M -27.55M -45.17M -37.19M -44.98M
EBITDA -4.33M -15.48M -33.06M -25.00M -32.69M
EPS Basic -0.30 -0.38 -0.44 -0.42 -0.46
Normalized Basic EPS -0.18 -0.23 -0.30 -0.27 -0.30
EPS Diluted -0.30 -0.38 -0.44 -0.42 -0.46
Normalized Diluted EPS -0.18 -0.23 -0.30 -0.27 -0.30
Average Basic Shares Outstanding 598.88M 586.95M 575.98M 565.04M 554.04M
Average Diluted Shares Outstanding 598.88M 586.95M 575.98M 565.04M 554.04M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --